176 related articles for article (PubMed ID: 29973960)
1. Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma.
Murugesan SN; Yadav BS; Maurya PK; Chaudhary A; Singh S; Mani A
J Genomics; 2018; 6():103-112. PubMed ID: 29973960
[TBL] [Abstract][Full Text] [Related]
2. Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas.
Murugesan SN; Yadav BS; Maurya PK; Chaudhary A; Singh S; Mani A
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180040
[TBL] [Abstract][Full Text] [Related]
3. YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: A comprehensive investigation through bioinformatics analysis and in vitro study.
Li Z; Lu W; Yin F; Huang A
Transl Oncol; 2024 Jul; 45():101965. PubMed ID: 38688048
[TBL] [Abstract][Full Text] [Related]
4. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer.
Liu Y; Zhao J; Zhang W; Gan J; Hu C; Huang G; Zhang Y
Sci Rep; 2015 May; 5():10159. PubMed ID: 25959498
[TBL] [Abstract][Full Text] [Related]
5. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract][Full Text] [Related]
6. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway.
Zheng X; Zhang J; Fang T; Wang X; Wang S; Ma Z; Xu Y; Han C; Sun M; Xu L; Wang J; Yin R
Oncogenesis; 2020 Mar; 9(3):34. PubMed ID: 32165621
[TBL] [Abstract][Full Text] [Related]
8. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.
Yang Z; Liu B; Lin T; Zhang Y; Zhang L; Wang M
J Cell Physiol; 2019 May; 234(5):7579-7586. PubMed ID: 30370535
[TBL] [Abstract][Full Text] [Related]
9. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
[TBL] [Abstract][Full Text] [Related]
10. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
Li X; Li B; Ran P; Wang L
Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725
[TBL] [Abstract][Full Text] [Related]
11. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
[TBL] [Abstract][Full Text] [Related]
12. Systems biology analysis reveals new insights into invasive lung cancer.
Li D; Yang W; Arthur C; Liu JS; Cruz-Niera C; Yang MQ
BMC Syst Biol; 2018 Dec; 12(Suppl 7):117. PubMed ID: 30547817
[TBL] [Abstract][Full Text] [Related]
13. Role of post-translational modification of the Y box binding protein 1 in human cancers.
Prabhu L; Hartley AV; Martin M; Warsame F; Sun E; Lu T
Genes Dis; 2015 Sep; 2(3):240-246. PubMed ID: 30258867
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
16. High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma.
Zhao S; Guo W; Li J; Yu W; Guo T; Deng W; Gu C
Onco Targets Ther; 2016; 9():2683-92. PubMed ID: 27217779
[TBL] [Abstract][Full Text] [Related]
17. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma.
Li S; Sun X; Miao S; Lu T; Wang Y; Liu J; Jiao W
Thorac Cancer; 2018 Aug; 9(8):924-930. PubMed ID: 29932500
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
Li L; Peng M; Xue W; Fan Z; Wang T; Lian J; Zhai Y; Lian W; Qin D; Zhao J
J Transl Med; 2018 Dec; 16(1):372. PubMed ID: 30587197
[TBL] [Abstract][Full Text] [Related]
19. YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma.
Xie Q; Zhao S; Liu W; Cui Y; Li F; Li Z; Guo T; Yu W; Guo W; Deng W; Gu C
Front Oncol; 2021; 11():702491. PubMed ID: 34976785
[TBL] [Abstract][Full Text] [Related]
20. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
